ATE199315T1 - Liposomzubereitungen enthaltend hybrid-interferon - Google Patents

Liposomzubereitungen enthaltend hybrid-interferon

Info

Publication number
ATE199315T1
ATE199315T1 AT95938532T AT95938532T ATE199315T1 AT E199315 T1 ATE199315 T1 AT E199315T1 AT 95938532 T AT95938532 T AT 95938532T AT 95938532 T AT95938532 T AT 95938532T AT E199315 T1 ATE199315 T1 AT E199315T1
Authority
AT
Austria
Prior art keywords
preparations containing
liposome preparations
containing hybrid
hybrid interferon
phospholipids
Prior art date
Application number
AT95938532T
Other languages
English (en)
Inventor
Peter William Taylor
Mohammed Akhlaq
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE199315T1 publication Critical patent/ATE199315T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95938532T 1994-12-08 1995-12-04 Liposomzubereitungen enthaltend hybrid-interferon ATE199315T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426484.3A GB9426484D0 (en) 1994-12-08 1994-12-08 Compositions
PCT/GB1995/002821 WO1996017596A1 (en) 1994-12-08 1995-12-04 Liposomal interferon hybrid compositions

Publications (1)

Publication Number Publication Date
ATE199315T1 true ATE199315T1 (de) 2001-03-15

Family

ID=10766773

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95938532T ATE199315T1 (de) 1994-12-08 1995-12-04 Liposomzubereitungen enthaltend hybrid-interferon

Country Status (12)

Country Link
EP (1) EP0799027B1 (de)
JP (1) JPH10510254A (de)
AT (1) ATE199315T1 (de)
AU (1) AU3989295A (de)
CA (1) CA2207292A1 (de)
DE (1) DE69520231T2 (de)
DK (1) DK0799027T3 (de)
ES (1) ES2156218T3 (de)
GB (1) GB9426484D0 (de)
GR (1) GR3035844T3 (de)
PT (1) PT799027E (de)
WO (1) WO1996017596A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006249479A1 (en) * 2005-05-23 2006-11-30 Sdg, Inc. Lipid construct for delivery of interferon to a mammal
WO2007014754A1 (en) * 2005-08-02 2007-02-08 I.D.M. Immuno-Designed Molecules Process for the preparation of liposomal formulations
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
MX2019010852A (es) * 2017-03-13 2019-10-30 Sdg Inc Nanoparticulas a base de lipidos con estabilidad mejorada.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009842B1 (de) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposome zur Freigabe von Arzneimitteln und eine ein Arzneimittelsystem mit liposomen enthaltende Bereitung
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
EP0331635A3 (de) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Zubereitungen zur Behandlung von Blasenkrebs.
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
DE4402867C1 (de) * 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen

Also Published As

Publication number Publication date
DE69520231T2 (de) 2001-08-16
CA2207292A1 (en) 1996-06-13
AU3989295A (en) 1996-06-26
DK0799027T3 (da) 2001-06-18
ES2156218T3 (es) 2001-06-16
PT799027E (pt) 2001-07-31
DE69520231D1 (de) 2001-04-05
EP0799027B1 (de) 2001-02-28
JPH10510254A (ja) 1998-10-06
WO1996017596A1 (en) 1996-06-13
GR3035844T3 (en) 2001-08-31
GB9426484D0 (en) 1995-03-08
EP0799027A1 (de) 1997-10-08

Similar Documents

Publication Publication Date Title
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
AU9260898A (en) Stable particulate complexes with neutral or negative global charge of lamellar structure
ATE172636T1 (de) Liposomales verabreichungssystem für biologisch aktive stoffe
WO1998019709A3 (en) Cationic reagents for transfection
ATE192657T1 (de) Arzneistoffzusammensetzung, die ein nukleinsäurecopolymer enthält
EA199900715A1 (ru) Липидные комплексы и липосомы совершенно нерастворимых комплексов платины
DE69923181D1 (de) Temperatursensitive liposomale formulierung
AU3780497A (en) Improvements in or relating to contrast agents
WO1997011682A3 (en) Emulsion and micellar formulations for the delivery of biologically active substances to cells
KR950700725A (ko) 리포솜 조성물(liposome composition)
ATE260643T1 (de) System zur verabreichung makromolekularer wirkstoffe auf der basis von membran-mimetischen amphiphilen in aerosolform
CA2168260A1 (en) Biphasic Multilamellar Lipid Vesicles
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
ATE199315T1 (de) Liposomzubereitungen enthaltend hybrid-interferon
EP0198765A3 (de) Herstellung von Liposomen
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
AU6083686A (en) Emulsion comprising lipid, non-lipid liquid and pharmaceutical ingredients
GB2188900B (en) Fusogenic phospholipid vesicles.
AU2002300073A1 (en) Preparation of a Lipid Blend and a Phospholipid Suspension Containing the Lipid Blend, and Contrast Agents Based on these

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee